Mutation to ispA Produces Stable Small-Colony Variants of Pseudomonas aeruginosa That Have Enhanced Aminoglycoside...

Area of Science:

• Microbiology
• Infectious Diseases
• Molecular Biology

Background:

• Pseudomonas aeruginosa is a significant pathogen in burn wound infections.
• Aminoglycoside antibiotics are commonly used for persistent bacterial infections.
• Small-colony variants (SCVs) are a phenotype associated with persistent infections and antibiotic tolerance.

Purpose of the Study:

• To report the emergence of Pseudomonas aeruginosa small-colony variants (SCVs) in a burn wound infection.
• To investigate the genetic basis and consequences of SCV emergence in P. aeruginosa.
• To explore the link between a specific gene mutation, SCV formation, and antibiotic resistance.

Main Methods:

• Clinical isolate collection from a patient with a persistent burn wound infection.
• Phenotypic characterization of P. aeruginosa isolates, including SCV identification.
• Genomic analysis to identify mutations, focusing on the ispA gene.
• Assessment of aminoglycoside resistance levels in wild-type and mutant strains.

Main Results:

• The study documented the emergence of P. aeruginosa SCVs from a patient undergoing aminoglycoside therapy for a burn wound infection.
• A single mutation in the ispA gene was identified as the cause of SCV emergence.
• This ispA mutation was directly linked to increased resistance to aminoglycoside antibiotics.
• IspA's role in ubiquinone synthesis suggests a connection between electron transport and SCV development.

Conclusions:

• The emergence of P. aeruginosa SCVs during aminoglycoside treatment is a clinically relevant phenomenon.
• A specific ispA mutation is a key driver for SCV formation and enhanced aminoglycoside resistance in P. aeruginosa.
• Understanding the mechanisms of SCV formation, such as the link to ubiquinone synthesis, is crucial for managing persistent infections.